Several studies have reported the activation of the PI3K/AKT signaling pathway by E2Fs in various human cancers, such as colorectal cancer (45), cervical squamous cell carcinoma (47), esophageal squamous cell carcinoma (48), and glioma (57). This evidence concerns the gene AKT1 and central nervous system cancer.